Takeda Pharmaceutical Co. Ltd. - Liabilities and Stockholders Equity

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.

The item "Liabilities-and-Stockholders-Equity" stands at 14.47 Trillion Japanese Yens as of 09/30/2025.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Liabilities and Stockholders Equity" stands at 14.47 Trillion JPY. This represents an increase of 3.33 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -0.7047 percent compared to the value the year prior.
The 1 year change in percent is -0.7047.
The 3 year change in percent is -0.8126.
The 5 year change in percent is 16.52.
The 10 year change in percent is 243.40.

The Serie's long term average value is 8.40 Trillion Japanese Yens. It's latest available value, on 09/30/2025, is 72.35 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2010, to it's latest available value, on 09/30/2025, is +439.92%.
The Serie's change in percent from it's maximum value, on 06/30/2024, to it's latest available value, on 09/30/2025, is -10.83%.